Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma

Surgery

Volumn 138, Issue 6, 2005, Pages 986-993

  Lorenz, Kerstin ^a   Brauckhoff, Michael ^a   Behrmann, Curd ^a   Sekulla, Carsten ^a   Ukkat, Jörg ^a   Brauckhoff, Katrin ^a   Gimm, Oliver ^a   Dralle, Henning ^a   Grant, Clive ^b   Evans, Douglas B ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Klinikum Kröllwitz ^*

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; EVALUATION; FATIGUE; FEMALE; HUMAN; LIVER FUNCTION; LIVER METASTASIS; MALE; NAUSEA; PAIN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SIDE EFFECT; THYROID MEDULLARY CARCINOMA;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, MEDULLARY; CHEMOEMBOLIZATION, THERAPEUTIC; EPIRUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; PROSPECTIVE STUDIES; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 29144439756     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.09.020     Document Type: Article

References (22)

1. B. Van Beers, and J. Pringot Hepatic metastases in medullary thyroid carcinoma: possible pitfall with MR imaging Eur J Radiol 11 1990 107 109
2. W.S. Tung, T.M. Vesely, and J.F. Moley Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer Surgery 118 1995 1024 1030
3. O. Esik, P. Szavcsur, S. Szakall, G. Bajzik, I. Repa, and G. Dabasi Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma Cancer 91 2001 2084 2095
4. P. Szavcsur, M. Gödeny, G. Bajzik, E. Lengyel, I. Repa, and L. Tron Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients Eur J Surg Oncol 31 2005 183 190
5. A. Machens, J. Ukkat, M. Brauckhoff, O. Gimm, and H. Dralle Advances in the management of hereditary medullary thyroid cancer J Int Med 257 2005 50 59
6. E. Miraille, J.P. Vuillez, S. Bardet, E. Frampas, B. Dupas, and L. Ferrer High frequency of bone/bone marrow involvement in advanced medullary thyroid cancer JC Endocrinol Metab 90 2005 779 788
7. A. Machens, U. Schneyer, H.H. Holzhausen, and H. Dralle Prospects of remission in MTC according to basal calcitonin level J Clin Metabol 90 2005 1 6
8. M. Brauckhoff, O. Gimm, K. Brauckhoff, J. Ukkat, O. Thomusch, and H. Dralle Calcitonin kinetics in the early postoperative period of medullary thyroid carcinoma Langenbeck's Arch Surg 386 2001 434 439
9. J.A. Van Heerden, C.S. Grant, H. Gharib, I.D. Hay, and D.M. Ilstrup Long-term course of patients with peristent hypercalcitonemia after apparent curative primary surgery for medullary thyroid carcinoma Ann Surg 212 1990 395 401
10. M. Nocera, E. Baudin, G. Pellegriti, A.F. Cailleux, C. Mechelany-Corone, and M. Schlumberger Treatment of advanced medullary thyroid cancer with an alternative combination of doxorubicin-streptozocin and 5 FU-dacarbazine Br J Cancer 83 2000 715 718
11. P. Rusznieweski, P. Rougier, A. Roche, P. Legmann, A. Sibert, and S. Hochlaf Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors Cancer 71 1993 2624 2630
12. J.M. Llovet, and J. Briux Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
13. O. Kress, H.J. Wagner, M. Wied, K.J. Klose, R. Arnold, and H. Alfke Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors - a retrospective single-center experience Digestion 9 2003 94 101
14. G. Fiorentini, S. Rossi, F. Bonechi, M. Vaira, M. de Simone, and P. Dentico Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study J Chemother 16 2004 293 297
15. S. Gupta, J.C. Yao, K. Ahrar, M.J. Wallaca, F.A. Morello, and D.C. Madoff Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience Cancer J 9 2003 261 267
16. A. Machens, C. Behrmann, and H. Dralle Chemoembolization of liver metastases from medullary thyroid carcinoma Ann Intern Med 132 2000 596 597
17. A. Machens, O. Gimm, J. Ukkat, R. Hinze, U. Schneyer, and H. Dralle Improved prediction of calcitonin normalization in MTC patients by quantitative lymph node analysis Cancer 88 2000 1909 1915
18. S.L. Hyer, L. Vini, R. A'Hern, and C. Harmer Medullary thyroid cancer: multivariate analyses of prognostic factors influencing survival Eur J Surg Oncol 26 2000 686 690
19. E. Kebebew, S. Kikuci, D. Quan-Yang, and O. Clark Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer Arch Surg 135 2000 895 901
20. L.E. Tisell, W.G. Dilley, and S.A. Wells Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels Surgery 119 1996 34 39
21. 90Y-DOTATOC J Nucl Med 43 2002 610 616
22. R.P. Baum, J. Soeldner, and M. Schmuecking Clinical results of peptide receptor radionuclide therapy (PRRT) with yttrium-90-DOTA-TYR3-OCTREOTATE (Y-90-DOTA-TATE) in patients with neuroendocrine tumors J Nucl Med 45 2004 90 99